SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
09-Sep-24 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-Sep-24 | Sale | 2,490 | $11.52 | $28,684.80 | (3%) 77.08K to 74.59K | |
09-Sep-24 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Sep-24 | Grant | 6,750 | -- | -- | 10% 70.33K to 77.08K | |
05-Sep-24 9:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Sep-24 | Sale | 514 | $9.51 | $4,887.78 | (< 1%) 70.85K to 70.33K | |
12-Apr-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Apr-24 | Sale | 54 | $6.74 | $363.96 | (< 1%) 70.9K to 70.85K | |
02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale | 3,818 | $8.53 | $32,572.50 | (5%) 74.72K to 70.9K | |
02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-24 | Grant | 25,000 | -- | -- | 50% 49.72K to 74.72K | |
25-Jan-24 4:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Jan-24 | Sale | 853 | $9.07 | $7,735.35 | (2%) 50.57K to 49.72K | |
05-Sep-23 8:15 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Sep-23 | Sale | 457 | $14.71 | $6,722.56 | (< 1%) 51.03K to 50.57K | |
12-May-23 4:14 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-May-23 | Sale | 455 | $16.59 | $7,548.45 | (< 1%) 51.49K to 51.03K | |
13-Apr-23 4:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Apr-23 | Sale | 47 | $21.49 | $1,010.03 | (< 1%) 51.53K to 51.49K | |
02-Feb-23 7:02 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-23 | Sale | 1,588 | $21.75 | $34,542.20 | (3%) 53.12K to 51.53K | |
02-Feb-23 7:02 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-23 | Grant | 20,250 | -- | -- | 62% 32.87K to 53.12K | |
26-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-23 | Sale | 852 | $21.90 | $18,662.50 | (3%) 33.72K to 32.87K | |
01-Sep-22 6:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Sep-22 | Grant | 5,000 | -- | -- | 17% 28.72K to 33.72K |